シングルユースバイオプロセシングの市場規模、シェア、動向分析：製品別、用途別、エンドユーザー別、地域別の展望、競合戦略、セグメント予測（～2030年）

世界のシングルユースバイオプロセシング市場は、2030年までに18.8%のCAGRで推移し、386億5,000万米ドルに達すると予測されています。水の浪費を減らす必要性、バイオ医薬品とエネルギー分野の研究開発への投資の増加、従来型よりもシングルユース技術が優れている点、交差汚染の脅威などが、当市場の拡大要因となっています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

• イントロダクション
• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
  • 課題
• COVID-19のシングルユースバイオプロセシング市場への影響
• 市場動向

第5章 世界のシングルユースバイオプロセシング市場：製品別（2019年～2030年）

• 使い捨てミキサー
• シングルユースアセンブリ
• シングルユースバイオリアクター
• シングルユース培地バッグおよび容器
• その他の製品

第6章 世界のシングルユースバイオプロセシング市場：用途別（2019年～2030年）

• 細胞培養
• ろ過
• 混合
• 精製
• 保管

第7章 世界のシングルユースバイオプロセシング市場：エンドユーザー別（2019年～2030年）

• 学術研究機関
• バイオ医薬品・製薬企業
• 医薬品開発業務受託機関 （CRO）・医薬品製造受託機関（CMO）

第8章 世界のシングルユースバイオプロセシング市場：地域別（2019年～2030年）

• 北米
  • 米国
  • カナダ
• 欧州
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • その他
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • その他
• ラテンアメリカ
• 中東
• アフリカ

第9章 競合情勢

• イントロダクション
• 市場シェア分析：主要企業別
• 競合シナリオ
  • 製品の発売
  • パートナーシップ、コラボレーション、契約
  • 買収
  • 拡張
  • その他の開発

第10章 企業プロファイル

• ABEC, Inc.
• Able Corporation & Biott Corporation
• Avantor
• bbi-biotech GmbH
• Cellexus
• Celltainer Biotech
• CESCO Bioengineering Co. Ltd.
• Corning
• Danaher Corporation
• Distek, Inc.
• Entegris
• Eppendorf AG
• G&G Technologies
• Getinge AB
• Kuhner AG
• Meissner Filtration Products, Inc.
• Merck KGaA
• OmniBRx Biotechnologies
• PBS Biotech, Inc.
• Pierre Guerin
• Sartorius Stedim Biotech S.A.
• Satake Chemical Equipment Mfg., Ltd.
• Solida Biotech GmbH
• Stobbe Pharma GmbH
• Thermo Fisher Scientific

第11章 付録

Global Single use Bio-processing Market is projected to be worth USD 38.65 billion by 2030.

According to SPER Market Research, the Single use Bio-processing Market is estimated to reach USD 38.65 billion by 2030 with a CAGR of 18.8%. The necessitate to diminish water wastage, growing investment in research & development in biopharmaceuticals & energy sector, pros of single use technologies than conventional one, and the threat of cross-contamination; are the fuels for the escalation of this market.

Impact of COVID-19 on the Single use Bio-processing Market

The outbreak of COVID-19, provide a positive growth in this market, big pharmaceutical and biopharmaceutical companies increased their investment in research & development, manufacturing of vaccines and test kits in large numbers.

Scope of the report:

• Market size available for years: 2019-2030
• Base year considered: 2021
• Forecast period: 2022-2030

• Segments covered: By Product, By Application, By End-Users, By Region

• Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa

Companies Covered

ABEC, Inc., Able Corporation & Biott Corporation, Avantor, bbi-biotech GmbH, Cellexus, Celltainer Biotech, CESCO Bioengineering Co. Ltd., Corning, Danaher Corporation, Distek, Inc., Entegris, Eppendorf AG, G&G Technologies, Getinge AB, Kuhner AG, Meissner Filtration Products, Inc., Merck KGaA, OmniBRx Biotechnologies, PBS Biotech, Inc., Pierre Guerin, Sartorius Stedim Biotech S.A., Satake Chemical Equipment Mfg., Ltd., Solida Biotech GmbH, Stobbe Pharma GmbH, Thermo Fisher Scientific

Driver: The increasing demand for biopharmaceuticals

Rising geriatric population, and are more prone to chronic diseases so the demand for biopharmaceuticals is likely to amplify. The use of single-use bio processing systems is increasing by the companies to match the demand for biopharmaceuticals. Consequently, the growing demand for biopharmaceuticals is the fuel for the growth of this market.

Challenges: Waste disposal

The increase in the use of single-use bio-processing systems by the Biopharmaceutical companies, solid waste disposal from this alternative technology is a matter of concern.

Opportunity: Emerging markets

Emerging economies have potential market for single-use bio-processing systems, providing vast opportunities for the players in this market.

Restraint: Issues related to leachables and extractables

Due to extractables and leachables; SOP concerning the contamination of single-use bio-processing system is not developed so far. Extractables and leachables are the restraints to the market.

Global Single use Bio-processing Market, by Product:

Based on the Product, Disposable mixers, Single use Bio-processing Market is segmented as; Single-use assemblies, Single-use bioreactors, Single-use media bags and containers, other products.

Global Single use Bio-processing Market, by Application:

Based on the Application, Single use Bio-processing Market is segmented as; Cell culture, Filtration, Mixing, Purification, and Storage.

Global Single use Bio-processing Market, by End-Users:

Based on the End-Users, Single use Bio-processing Market is segmented as; Academic & Research institutes, Biopharmaceutical & Pharmaceutical Company

Global Single use Bio-processing Market, by Region:

North America owns the biggest share of market; it is due to the demand for biopharmaceuticals is going up, this is the fuel for the escalation of Single use Bio-processing Market in North America.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
  • 4.2.4. Challenges
• 4.3. COVID-19 Impact on the Single use Bio-processing Market
• 4.4. Market Trends

5. Global Single use Bio-processing Market, by Product, 2019-2030 (USD Million)

• 5.1. Disposable mixers
• 5.2. Single-use assemblies
• 5.3. Single-use bioreactors
• 5.4. Single-use media bags and containers
• 5.5. Other products

6. Global Single use Bio-processing Market, by Application, 2019-2030 (USD Million)

• 6.1. Cell culture
• 6.2. Filtration
• 6.3. Mixing
• 6.4. Purification
• 6.5. Storage

7. Global Single use Bio-processing Market, by End-Users, 2019-2030 (USD Million)

• 7.1. Academic & Research institutes
• 7.2. Biopharmaceutical & Pharmaceutical companies
• 7.3. Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)

8. Global Single use Bio-processing Market, by Region, 2019-2030 (USD Million)

• 8.1. North America
  • 8.1.1. US
  • 8.1.2. Canada
• 8.2. Europe
  • 8.2.1. France
  • 8.2.2. Germany
  • 8.2.3. Italy
  • 8.2.4. Spain
  • 8.2.5. Rest of the Europe
• 8.3. Asia Pacific
  • 8.3.1. China
  • 8.3.2. India
  • 8.3.3. Japan
  • 8.3.4. Rest of Asia Pacific
• 8.4. Latin America
• 8.5. Middle East
• 8.6. Africa

9. Competitive Landscape

• 9.1. Introduction
• 9.2. Market Share Analysis, By Key Players
• 9.3. Competitive Scenario
  • 9.3.1. Product Launches
  • 9.3.2. Partnerships, Collaborations and Agreements
  • 9.3.3. Acquisitions
  • 9.3.4. Expansions
  • 9.3.5. Other Developments

10. Company Profiles

• 10.1. ABEC, Inc.
• 10.2. Able Corporation & Biott Corporation
• 10.3. Avantor
• 10.4. bbi-biotech GmbH
• 10.5. Cellexus
• 10.6. Celltainer Biotech
• 10.7. CESCO Bioengineering Co. Ltd.
• 10.8. Corning
• 10.9. Danaher Corporation
• 10.10. Distek, Inc.
• 10.11. Entegris
• 10.12. Eppendorf AG
• 10.13. G&G Technologies
• 10.14. Getinge AB
• 10.15. Kuhner AG
• 10.16. Meissner Filtration Products, Inc.
• 10.17. Merck KGaA
• 10.18. OmniBRx Biotechnologies
• 10.19. PBS Biotech, Inc.
• 10.20. Pierre Guerin
• 10.21. Sartorius Stedim Biotech S.A.
• 10.22. Satake Chemical Equipment Mfg., Ltd.
• 10.23. Solida Biotech GmbH
• 10.24. Stobbe Pharma GmbH
• 10.25. Thermo Fisher Scientific

11. Appendix